期刊文献+

Modulation of histamine release from human colon mast cells by protease inhibitors 被引量:7

Modulation of histamine release from human colon mast cells by protease inhibitors
暂未订购
导出
摘要 AIM:To investigate the ability of protease inhibitors to modulate histamine release from human colon mast cells.METHODS: Enzymatically dispersed cells from human colon were challenged with anti-IgE or calcium ionophore A23187 in the absence or presence of tryptase and chymase inhibitors, and histamine release was determined.RESULTS: IgE dependent histamine release from colon mast ceils was inhibited by up to approximately 37%, 26% and 36.8% by chymase inhibitors Z-Ile-Glu-Pro-Phe-CO2 Me(ZIGPFM), N-TosyI-L-phenylalanyl-chloromethyl ketone (TPCK), and C^l-antitrypsin, respectively. Similarly, inhibitors of tryptase leupeptin, N-tosyI-L-lysine chloromethyl ketone (TLCK), lactoferrin and protamine were also able to inhibit anti-IgE induced histamine release by a maximum of some 48%,37%,40% and 34%, respectively. Preincubation of these inhibitors with cells for 20 rain before challenged with anti-IgE had small effect on the inhibitory actions of these inhibitors on colon mast cells. A specific inhibitor of aminopeptidase amastatin had no effect on anti-IgE induced histamine release. The significant inhibition of calcium ionophore induced histamine release was also observed with the inhibitors of tryptase and chymase examined. Apart from leupeptin and protamine, the inhibitors tested by themselves did not stimulate colon mast cells.CONCLUSION: It was demonstrated that both tryptase and chymase inhibitors could inhibit IgE dependent and calcium ionophore induced histamine release from dispersed colon mast cells in a concentration dependent of manner, which suggest that they are likely to be developed as a novel class of anti-inflammatory drugs to treat chronic of colitis in man. AIM:To investigate the ability of protease inhibitors to modulate histamine release from human colon mast cells. METHODS:Enzymatically dispersed cells from human colon were challenged with anti-IgE or calcium ionophore A23187 in the absence or presence of tryptase and chymase inhibitors,and histamine release was determined. RESULTS:IgE dependent histamine release from colon mast cells was inhibited by up to approximately 37%,26% and 36.8% by chymase inhibitors Z-Ile-Glu-Pro-Phe-CO_2Me (ZIGPFM),N-TosyI-L-phenylalanyl-chloromethyl ketone (TPCK),and α_1-antitrypsin,respectively.Similarly,inhibitors of tryptase leupeptin,N-tosyI-L-lysine chloromethyl ketone (TLCK),lactoferrin and protamine were also able to inhibit anti-IgE induced histamine release by a maximum of some 48%,37%,40% and 34%,respectively.Preincubation of these inhibitors with cells for 20 min before challenged with anti-IgE had small effect on the inhibitory actions of these inhibitors on colon mast cells.A specific inhibitor of aminopeptidase amastatin had no effect on anti-IgE induced histamine release.The significant inhibition of calcium ionophore induced histamine release was also observed with the inhibitors of tryptase and chymase examined.Apart from leupeptin and protamine,the inhibitors tested by themselves did not stimulate colon mast cells. CONCLUSION:It was demonstrated that both tryptase and chymase inhibitors could inhibit IgE dependent and calcium ionophore induced histamine release from dispersed colon mast cells in a concentration dependent of manner,which suggest that they are likely to be developed as a novel class of anti-inflammatory drugs to treat chronic of colitis in man.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第3期337-341,共5页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China,No.30140023,and the Li Ka Shing Foundation,Hong Kong,China,No.C0200001
  • 相关文献

参考文献2

二级参考文献34

  • 1Abraham WM. Tryptase: potential role in airway inflammation and remodelling. Am J Physiol Lung Cell Mol Physiol 2002; 282: L193-6.
  • 2McEuen AR, He S, Brander ML, Walls AE Guinea pig lung tryptase: localisation to mast cells and characterisation of the partially purified enzyme. Biochem Pharmacol 1996; 52:331-40.
  • 3Schwartz LB, Lewis RA, Seldin D, Austen KF. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol 1981; 126: 1290-4.
  • 4Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B.Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001; 357: 361-2.
  • 5Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 2000; 106: 57-64.
  • 6Bruno G, Andreozzi P, Bracchitta S, Graf U, Santangelo G,Zaino S, et al. Serum tryptase in allergic rhinitis: effect of cetirizine and fluticasone propionate treatment. Clin Ter 2001; 152: 299-303.
  • 7Buckley MG, Waiters C, Brander M, Wong WM, Cawley MI, Ren S, etaL Mast cell activation in arthritis: detection of a and β tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci 1997; 93: 363-70.
  • 8Walls AF. Structure and function of human mast cell tryptase.In: Marone G, editor. Mast ceils and basophils. New York:Academic Press; 2000. p 291-309.
  • 9He S, Wails AF. Human mast cell tryptase: a potent stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 1997; 328: 89-97.
  • 10Mofinari JF, Scuff M, Moore WR, Clark J, Tanaka R, Abraham WM. Inhaled tryptase causes bronchoconstriction in sheep via histamine release. Am J Respir Crit Care Med 1996; 154:649-53.

共引文献25

同被引文献17

引证文献7

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部